PITTSBURGH —A molecular test called PancreaSeq accurately classifies pancreatic cysts as potentially cancerous or benign, according to a large, multi-center study led by University of Pittsburgh School of Medicine and UPMC researchers.
PITTSBURGH —A molecular test called PancreaSeq accurately classifies pancreatic cysts as potentially cancerous or benign, according to a large, multi-center study led by University of Pittsburgh School of Medicine and UPMC researchers.
Nikiforova MN, Wald AI, Spagnolo DM, Melan MA, Grupillo M, et al. Ann Surg. 2023 May 22.
Paniccia A, Polanco PM, Boone BA, Wald AI, McGrath K, et al. Gastroenterology. 2023 Jan;164(1):117-133.e7.
Pitman MB, Centeno BA, Reid MD, Siddiqui MT, Layfield LJ, et al. Acta Cytol. 2023;67(3):304-320.
Fischer CG, Beleva Guthrie V, Braxton AM, Zheng L, Wang P, et al. Gastroenterology. 201 Oct;157(4):1123-1137.e22.
Springer S, Masica DL, Dal Molin M, Douville C, Thoburn CJ, et al. Sci Transl Med. 2019 Jul 17;11(501):eaav4772.
Springer S, Wang Y, Dal Molin M, Masica DL, Jiao Y, et al. Gastroenterology. 2015 Nov;149(6):1501-10.
Amato E, Molin MD, Mafficini A, Yu J, Malleo G, et al. J Pathol. 2014 Jul;233(3):217-27.
Wu J, Matthaei H, Maitra A, Dal Molin M, Wood LD, et al. Sci Transl Med. 2011 Jul 20;3(92):92ra66.
PancreaSeq is a product of the Molecular & Genomic Pathology Laboratory at the University of Pittsburgh Medical Center.